Qi Liu
- Molecular Biology top 2%
- Computational Theory and Mathematics top 1%
- Cancer Research top 5%
- Oncology top 10%
- Immunology top 10%
- Topics
- CRISPR and Genetic Engineering (23 papers)Computational Drug Discovery Methods (22 papers)Single-cell and spatial transcriptomics (21 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Qi Liu
126 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Molecular Biology 2.6k
- Computational Theory and Mathematics 535
- Cancer Research 394
- Oncology 392
- Immunology 336
Countries citing papers authored by Qi Liu
This map shows the geographic impact of Qi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Liu more than expected).
Fields of papers citing papers by Qi Liu
This network shows the impact of papers produced by Qi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Liu. The network helps show where Qi Liu may publish in the future.
Co-authorship network of co-authors of Qi Liu
This figure shows the co-authorship network connecting the top 25 collaborators of Qi Liu. A scholar is included among the top collaborators of Qi Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Liu. Qi Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 7 | |
| 4 | 3 | |
| 5 | 26 | |
| 6 | 36 | |
| 7 | 3 | |
| 8 | 9 | |
| 9 | 25 | |
| 10 | 37 | |
| 11 | 4 | |
| 12 | 32 | |
| 13 | 46 | |
| 14 | 55 | |
| 15 | Novel Albumin Nanoparticle Enhanced the Anti-Insulin-Resistant-Hepatoma Activity of Metformin | 1 |
| 16 | 94 | |
| 17 | 30 | |
| 18 | 12 | |
| 19 | 9 | |
| 20 | 18 |
About Qi Liu
Qi Liu is a scholar working on Computational Theory and Mathematics, Business and International Management and Molecular Biology, having authored 137 papers that have together received 3.6k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (23 papers), Computational Drug Discovery Methods (22 papers) and Single-cell and spatial transcriptomics (21 papers). The work is most often cited by research in Business and International Management (98 citations), Aging (70 citations) and Molecular Biology (2.6k citations). Qi Liu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guohui Chuai, Chi Zhou, Chenyu Zhu, Ruixin Zhu, Jingchun Sun, Hua Xu, Yubo Zhou, Bin Duan, Dongyu Xue and Qiang Wei. Their work appears in journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.